Diseases, Conditions, Syndromes

Candidate tuberculosis vaccine in phase II/III trial

Tuberculosis remains the most deadly infectious diseases in the world. In particular, the growing number of multiresistant microbes is a cause of great concern to doctors and healthcare policymakers. At least a dozen candidate ...

Diseases, Conditions, Syndromes

How tuberculosis bacteria hide in the body

Tuberculosis bacteria hide in the very cells that would normally kill them. Now we know more about how they evade recognition. Tuberculosis affects millions of people worldwide. Treatment is often prolonged, from six months ...

Diseases, Conditions, Syndromes

Time to put TB on a diet

Global Tuberculosis Report, the disease kills over 1.5 million people a year. Although the mortality rate has dropped by 47% since 1990 due to advances in preventive and treatment options, the tuberculosis bacillus is growing ...

Diseases, Conditions, Syndromes

Cleverly designed tuberculosis vaccine shows promise in mice

A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, ...

Diseases, Conditions, Syndromes

Tuberculosis and HIV co-infection

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at Linköping University in Sweden. ...

page 1 from 5